Skip to main content
Caplight Logo









Reconnect Labs

Reconnect Labs

Private
ZurichHealthcare & Life Scienceshttps://reconnect-labs.com/

Last Round

Series A

Aug 20, 2025

Total Funding Raised

$24.64M

Company Overview

Reconnect Labs is a biopharmaceutical company developing precision therapeutics and predictive diagnostics for sleep, anxiety, and substance use disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

psychedelic pharmaneuropsychiatric drug developmentpsychedelic biotechprecision psychiatryclinical-stage biopharmamental health therapeuticsAI drug discoveryshort-acting psychedelicsDMT therapycompanion diagnostics5-MeO-DMTdigital psychiatryinsomnia treatmentchronic pain treatmentanxiety treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reconnect Labs Comparables

Compare Reconnect Labs with similar companies based on industry and business-model similarity.

Reconnect Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reunion Neuroscience Inc.
81%
Gilgamesh Pharmaceuticals
79%
GH Research
79%

Reconnect Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 20, 2025
GrantAug 20, 2025
SeedMay 21, 2021

Key People

Founding team and executive leadership

Davor Kosanic

CEO & Co-founder

Founding Team

Reconnect Labs Investors

Notable investors and investment history

Reconnect Labs investors
InvestorRounds
Lionheart VenturesSeries A, Seed
re.Mind CapitalSeed
Apeiron Investment GroupSeed
EsperanteSeries A, Seed
Negev CapitalSeries A, Seed
Noetic FundSeries A, Seed
InnosuisseGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 134% MoM, reaching 2.6K.

  • Aug 20, 2025

    $11.2M grant received from Innosuisse.

Reconnect Labs Filings

Explore SEC and related filing metadata, where available.

Reconnect Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Reconnect Labs's valuation, stock price, and market status.

Is Reconnect Labs a public or private company?

Reconnect Labs is a private company.

What is the current stock price of Reconnect Labs?

Reconnect Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Reconnect Labs worth (valuation)?

Valuation information for Reconnect Labs is not publicly available.

Can I buy Reconnect Labs stock?

Reconnect Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Reconnect Labs's last funding round?

Funding round information for Reconnect Labs is not publicly available.

Who are the main investors in Reconnect Labs?

Investor information for Reconnect Labs is not publicly disclosed.

Will Reconnect Labs IPO soon?

No public IPO plans have been announced for Reconnect Labs.

How can I track Reconnect Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reconnect Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range8
Year Founded2021
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?